Zepbound vs Wegovy Cost in 2026: Full Price Comparison
Key Takeaways
- Wegovy is cheaper at every self-pay tier — $149/month (pill) vs. Zepbound's $299/month entry
- At maintenance doses: Wegovy pen $349/month vs. Zepbound $449/month
- Both cost $50/month through Medicare Bridge and $25/month with commercial insurance + savings card
- Clinical trials show tirzepatide (Zepbound) produces ~5–7% more weight loss than semaglutide (Wegovy) on average
- 12-month self-pay total: Wegovy pill ~$3,190 vs. Zepbound ~$5,039
Wegovy and Zepbound are the two dominant GLP-1 weight loss medications in 2026, and "which one is cheaper?" is one of the most common questions people ask before starting treatment. The short answer: Wegovy costs less at every self-pay price point. The longer answer: the clinical difference might justify Zepbound's premium for some patients.
This guide compares every cost pathway side by side.
Full Price Comparison: Every Pathway
| Access Pathway | Wegovy | Zepbound | Difference |
|---|---|---|---|
| Cheapest self-pay entry | $149/mo (pill) | $299/mo | Wegovy saves $150 |
| Injection entry (intro) | $199/mo* | $299/mo | Wegovy saves $100 |
| Injection maintenance | $349/mo | $449/mo | Wegovy saves $100 |
| High dose | $399/mo (7.2 mg) | $449/mo (15 mg) | Wegovy saves $50 |
| Subscription (3-month) | $329/mo | N/A | Wegovy only |
| Insurance + savings card | $25/mo | $25/mo | Tied |
| Medicare Bridge | $50/mo | $50/mo | Tied |
| TrumpRx | ~$199–$350 | ~$299–$346 | Comparable |
| List price (retail) | $1,349/mo | $1,086/mo | Zepbound lower list |
*Wegovy $199 intro for first 2 months on starter doses through 8/31/2026. Zepbound 45-day refill rule applies on 7.5 mg+ doses.
12-Month Cost Comparison
| Scenario | Wegovy Pill | Wegovy Pen | Zepbound (LillyDirect) |
|---|---|---|---|
| 12-month total (self-pay) | ~$3,190 | ~$3,892 | ~$5,039 |
| 12-month total (Medicare) | $600 | $600 | $600 |
| 12-month total (insured) | $300 | $300 | $300 |
The Clinical Trade-Off
Zepbound's higher price reflects a real clinical difference: tirzepatide is a dual GIP/GLP-1 receptor agonist that targets two hunger-signaling pathways, while Wegovy (semaglutide) targets one. In head-to-head-adjacent trial data, tirzepatide produced approximately 5–7% more total body weight loss than semaglutide at their respective maximum doses.
Whether that additional weight loss is worth $100–$150/month more depends on your goals, your starting point, and how you respond to each medication. Some patients do better on one than the other regardless of average trial results.
Which Should You Choose?
Choose Wegovy if: Budget is a top priority, you want the oral pill option ($149/month entry), or your insurance covers Wegovy but not Zepbound.
Choose Zepbound if: Maximum weight loss is the priority, you can afford $449/month, or your insurance covers Zepbound (making the cost equal).
If you have insurance or Medicare: The cost is the same ($25 or $50/month). In that case, discuss clinical fit with your doctor — let efficacy and side-effect profiles guide the decision, not price.
Injectable semaglutide
Compounded medications are prepared by pharmacies and are not FDA-approved. They have not been evaluated for safety, efficacy, or manufacturing quality by the FDA.
Check Current Pricing →Paid link · We may earn a commission
Injectable tirzepatide
Compounded medications are prepared by pharmacies and are not FDA-approved. They have not been evaluated for safety, efficacy, or manufacturing quality by the FDA.
Check Current Pricing →Paid link · We may earn a commission
Wegovy is the cheaper option at every self-pay tier, saving $100–$150/month vs. Zepbound. Over a year, that's $1,150–$1,850 in savings. The clinical case for Zepbound (more weight loss on average) is real but doesn't change the math for most budget-conscious patients. If insurance or Medicare equalizes the cost, let your doctor guide the clinical decision.
Prices verified as of July 15, 2026. Clinical comparisons reference STEP (semaglutide) and SURMOUNT (tirzepatide) trial programs. This is not medical advice.